Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-11

Clinical Trial Update: Development of A Novel Anti-Hyperglycemic Agent [Phase 2]

View source ↗

Summary

A Phase 2 trial of a novel anti-hyperglycemic agent for diabetes was terminated, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: VA Office of Research and Development | Conditions: Diabetes | Phase 2 | Status: TERMINATED | Results posted: 2015-02-11